ArticleNature reviews. Clinical oncology2025

Daratumumab and missed sequencing opportunities in transplant-ineligible multiple myeloma: lessons for future trials.

Ghulam Rehman Mohyuddin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.